The IPO is commanding a GMP of 40%, suggesting strong listing gains potential. At the upper price band of Rs 145, the expected listing price in the unofficial market is around Rs 200–205 per share.
The price band has been fixed at Rs 137–145 per share, with investors required to apply for a minimum of 2,000 shares, translating into an investment of Rs 2.74 lakh at the upper band.
Narnolia Financial Services is the book-running lead manager, while Maashitla Securities is the registrar to the issue.
Ahead of the IPO opening, Anondita Medicare raised Rs 19.58 crore from anchor investors on August 21, 2025, by allotting 13.5 lakh shares.
About the company
Founded in March 2024, the Noida-based company manufactures male condoms under the flagship “COBRA” brand, with an annual capacity of 562 million units.
The firm exports to Southeast Asia, Africa, and the Middle East, and has partnerships with NGOs, governments, and global health organisations for family planning and public health initiatives.
The company has shown rapid growth, with revenue rising 66% to Rs 77.13 crore in FY25 from Rs 46.56 crore in FY24. Profit after tax surged 327% to Rs 16.42 crore in the same period.